Table 8Further SAR elucidation Scaffold II – series E

Image ml262fu5.jpg
EntryCIDSIDS/PR1R2AML12 IC50 (nM)*
1E9550710103061845PPhbenzo[d][1,3]dioxol-5-ylmethanamine412
2E49852482104222755SH(3,4-dimethoxyphenyl)methanamine>10000
3E
ML262
20855303104222756SPh2-(3,4-diethoxyphenyl)ethanamine6.39
4E49852486104222757SPh2-(3-ethoxy-4-methoxyphenyl)ethanamine42.8
5E20855299104222758SPh2-(3,4-dimethoxyphenyl)ethanamine186
6E39969257104222759SPh2-(benzo[d][1,3]dioxol-5-yl)ethanamine3260
7E49852487104222760SPh2-(4-ethoxy-3-methoxyphenyl)ethanamine21.6
8E24512645104222761SPh(3,4-dimethoxyphenyl)methanamine101
*

no cytotoxicity at 33 μM (highest concentration tested); so CC50 >33 μM by HCS cytotoxicity index

From: Potent inhibitors of lipid droplet formation

Cover of Probe Reports from the NIH Molecular Libraries Program
Probe Reports from the NIH Molecular Libraries Program [Internet].

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.